Increased tendency to bruise/bruises easily; Early morning stiffness/stiff in morning when wakes up; Feeling of warmth/trouble with heat; Lost weight; Hidradenitis suppurativa flares up; Hidradenitis suppurativa flares up; Nausea from second COVID shot; Headache from  second COVID shot; This spontaneous case was reported by a consumer and describes the occurrence of INCREASED TENDENCY TO BRUISE (Increased tendency to bruise/bruises easily), MUSCULOSKELETAL STIFFNESS (Early morning stiffness/stiff in morning when wakes up), FEELING HOT (Feeling of warmth/trouble with heat), WEIGHT DECREASED (Lost weight) and HIDRADENITIS (Hidradenitis suppurativa flares up) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product  (HUMIRA) for Hidradenitis suppurativa.    No Medical History information was reported.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-May-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, ADALIMUMAB (HUMIRA) (Subcutaneous) dosage was changed to Citrate free. On 08-Mar-2021, the patient experienced NAUSEA (Nausea from second COVID shot) and HEADACHE (Headache from  second COVID shot). In 2022, the patient experienced WEIGHT DECREASED (Lost weight), HIDRADENITIS (Hidradenitis suppurativa flares up) and CONDITION AGGRAVATED (Hidradenitis suppurativa flares up). On an unknown date, the patient experienced INCREASED TENDENCY TO BRUISE (Increased tendency to bruise/bruises easily), MUSCULOSKELETAL STIFFNESS (Early morning stiffness/stiff in morning when wakes up) and FEELING HOT (Feeling of warmth/trouble with heat). On 09-Mar-2021, NAUSEA (Nausea from second COVID shot) and HEADACHE (Headache from  second COVID shot) had resolved. In 2022, WEIGHT DECREASED (Lost weight), HIDRADENITIS (Hidradenitis suppurativa flares up) and CONDITION AGGRAVATED (Hidradenitis suppurativa flares up) had resolved. At the time of the report, INCREASED TENDENCY TO BRUISE (Increased tendency to bruise/bruises easily), MUSCULOSKELETAL STIFFNESS (Early morning stiffness/stiff in morning when wakes up) and FEELING HOT (Feeling of warmth/trouble with heat) outcome was unknown.            Concomitant product use was not provided by the reporter. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. The reporter's causality for the event(s) of BRUISES EASILY with HUMIRA(ADALIMUMAB) was no reasonable possibility. The reporter's causality for the event(s) of STIFF IN MORNING WHEN WAKES UP and HEADACHES FROM  COVID-19 VACCINE was not provided. The reporter's causality for the event(s) of LOST WEIGHT, TROUBLE WITH HEAT, HIDRADENITIS SUPPURATIVA FLARES UP, NAUSEA FROM SECOND COVID SHOT and HEADACHE FROM SECOND COVID SHOT with HUMIRA(ADALIMUMAB) was no reasonable possibility. Treatment information was not provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna    Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2022:  significant follow up: events added, dosage updated, narrative updated.